Urolithin A and its potent synthetic analogue, UAS03, protect against colon diseases by enhancing barrier functions and reducing inflammation through upregulation of epithelial TJ proteins via activation of AhR-nuclear factor erythroid 2-related factor 2 (NRF2)-dependent pathways (Singh et al., 2019a). Here, NFE2L2 is linked to colonic disorder.